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INTRODUCTION
Cancer has been the leading cause of death in Korea since 
1983 due to the aging population and tremendous changes in 
lifestyle, and one out six Koreans died of cancer that year. The 
proportion of cancer deaths has increased every year since then, 
accounting for 33.4% of all deaths in 2009 [1]. This means that 
more than one of every four Koreans is a victim of cancer. In-
creases in life expectancy also cause increase in cancer incidence. 
One of three men who lives to the age of 77 may develop can-
cer, and three of ten women who lives to age 83 may develop 
cancer. During the first term of the 10-year plan of National 
Cancer Control since 1995, a significant reduction in cancer 
mortality rates for stomach and liver cancer was observed in 
men, and cervical cancer in women in Korea. However, mor-
talities from lung and colon cancer in men and breast cancer 
in women have increased. Lung cancer mortality decreased in 
men during the latter period of the first term [2]. The most dra-
matic change has comes from breast cancer. The percent in-
crease in breast cancer mortality for middle-aged women from 
the mid-1980s to the mid-1990s was the highest in Korea, fol-
lowed by China, and Japan [3-5].
In particular, the incidence of breast cancer, which was previ-
ously the second leading cause of cancer in Korea, has increased 
6.8% annually during the last 6 years. This is a unique epide-
miological feature that has been observed in Asia over the past 
few decades. Among men, stomach cancer has the highest oc-
currence, followed by lung, liver, colorectal, and prostate. In 
women, the two most common cancers are breast and thyroid, 
followed by stomach, colorectal, lung, and cervical [2,6].
RISK FACTORS OF BREAST CANCER
Risk factors for breast cancer identified in Korea
Beginning in the early 1990s, two large-scale multi-center 
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Due to the aging population and tremendous changes in life style 
over the past decades, cancer has been the leading cause of 
death in Korea. The incidence rate of breast cancer is the sec-
ond highest in Korea, and it has shown an annual increase of 
6.8% for the past 6 years. The major risk factors of breast can-
cer in Korean women are as follows: Early menarche, late meno-
pause, late full-term pregnancy (FTP), and low numbers of FTP . 
Height and body mass index increased the risk of breast cancer 
in postmenopausal women only. There are ethnic variations in 
breast cancer due to the differences in genetic susceptibility or 
exposure to etiologic agent. With the epidemiological evidences 
on the possibility of further increase of breast cancer in Korea, 
the Korean Government began implementing the National Can-
cer Screening Program against breast cancer in 2002. Five-year 
survival rates for female breast cancer have improved significant-
ly from 78.0% in early 1993-1995 to 90.0% in 2004-2008. This 
data indicate that improvement of the survival rate may be par-
tially due to the early diagnosis of breast cancer as well as the 
increased public awareness about the significance of early detec-
tion and organized cancer screening program. The current pri- 
mary prevention programs are geared towards strengthening na-
tional prevention campaigns. In accordance with the improve-
ment in 5-year survival rate, the overall cancer mortality has start-
ed to decrease. However, breast cancer death rate and incidence 
rates are still increasing, which need further organized effort by 
the Korean Government.
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case-control studies were conducted to identify breast cancer 
risk factors in Korea. A fundamental question was whether there 
were differences in established risk and protective factors be-
tween Western and Korean women. As a result, the main breast 
cancer risk factors in Korean women early age at menarche, 
which was rather weak but significant, and late age at meno-
pause. Late age at first full-term pregnancy (FTP) and a small-
er number of FTPs clearly showed an increased risk for breast 
cancer, probably due to changes in breast tissue susceptibility 
or to hormonal milieu [7,8]. A dose-dependent increasing trend 
for breast cancer risk occurs as a result of life-time exposure to 
estrogen, which is roughly defined by the interval between men-
arche and menopause. Breast feeding has been a controversial 
subject among breast cancer epidemiologists. A longer dura-
tion of breast feeding per child has a protective effect against 
breast cancer, independent of parity. This is particularly evident 
when the analysis is restricted to the first child [9]. Similar find-
ings have been published in Japan [10,11].
Height is also a risk factor for breast cancer but is significant 
only for postmenopausal women, which might be related to 
growth factors. Similarly, obesity, indicated by body mass in-
dex, increases the risk of breast cancer in postmenopausal wom-
en [12,13]. This is a very similar to findings observed in the 
U.S. and Japan [14], which is highly relevant to the estrogen-
augmented-by-progesterone hypothesis [15]. Despite the pos-
sibility of recall bias in this case-control study, late teen body 
weight showed a statistically significant association with breast 
cancer risk only in postmenopausal women, which supports 
nutritional status adolescents [9].
Most of the established risk and protective factors observed 
in Western countries are similarly observed in Korean women. 
However, risk factors such as smoking, physical inactivity, non-
steroidal anti-inflammatory drug and oral contraceptives use, 
as well as exposure to ionizing radiation need to be further eval-
uated. Evidence suggests that most of the risk factors are close-
ly related with estrogen and progesterone levels, which have 
been hypothesized to be causative agents in breast cancer eti-
ology. Among the risk factors identified in a Korean study, the 
protective effect of breast feeding against breast cancer is gen-
erally more prominent in Asian countries, whereas early men-
arche and hormone replacement therapy show a very weak as-
sociation, and postmenopausal obesity shows a moderate asso-
ciation.
Reasons for international variations in breast cancer incidence
The next question is why is there such a wide variation in 
cancer incidence throughout the world, even though many com-
mon risk factors for breast cancer are shared among different 
countries. Apparently the incidence is highest in North Amer-
ica, Western Europe, and Australia, whereas it is relatively low 
in Japan and Korea. 
One of the reasons is that the magnitude of exposure to eti-
ological agents may be different by ethnicity and country. Se-
rum levels of 17β-estradiol (E2) among Korean women are 
much lower than those of Western women [16] and even low-
er than those of Japanese women [17]. Differences in the rela-
tive exposure to risk factors may be an explanation for the eth-
nic differences in breast cancer incidence.
One of the explanations of why Koreans have been maintain-
ing such a lower incidence compared to Western women may 
be differences in hormone receptor status. It is well-known that 
receptor positivity is essential for breast cancer development, 
and the age-incidence curve is dependent on how many cases 
have the receptor in the population [18]. Estrogen receptor (ER) 
or progesterone (PG) receptor (PR) positivity is about 65.9% 
among breast cancer cases, whereas a lower frequency of ER/
PR expression occurs in Korean women.
Age incidence curve of breast cancer
Recent statistics on age-specific female breast cancer rates 
among Korean females appear to be somewhat different figures 
stomach, lung, and colorectal cancers rates, showing their high-
est peak in the 45-49 years age group. A similar finding has also 
been observed for thyroid cancer. Although the breast cancer 
incidence has more than doubled in the last decade, the peak 
age group has not changed [19]. The age incidence curve of 
breast cancer is partly influenced by hormones receptor status 
of the Korean female population. However, it must be empha-
sized that there is a strong generational cohort effect in terms 
of breast cancer occurrence in Korean women. It has been dem-
onstrated that the number of people in their late 60-70s was 
1.2 to 2.1 times higher in 2003 than it was in 1984. These data 
are based on the age-cohort effect model [20].
Another reason may be due to the marked increase in breast 
cancer screening experience particularly in middle-aged Kore-
an women, i.e., higher rate of screening rates among women 
aged in their 40s and 50s, which is compatible with the age-in-
cidence curve findings [19]. Particularly, in large metropolitan 
areas including Seoul, more educated and more prosperous 
women tend to visit private breast clinics more frequently to 
undergo breast cancer examinations at their own expense or 
using private health insurance. This would be one reason why 
the incidence of breast cancer is high in middle-aged women 
in Korea.
Based on this evidences, it can be speculated that, when the 
occurrence of breast cancer increases to 80 or more than 100 
per 100,000 persons in the future in Korea, it will influence 
the increase in serum E2/PG level, the most significant risk BreastCancerinKorea 81
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factor. Furthermore, the proportion of women with positive 
ER/PR will reach more than 80%, and ultimately the age curve 
will be changed to that of the current curve observed in West-
ern women.
GENETIC POLYMORPHISMS OF  
BREAST CANCER
Differences in genetic susceptibility to breast cancer
Human genetic variations are involved associated with dis-
ease susceptibility. Different from the concepts of gene varia-
tion in biomarkers, genetic variations in human genome epi-
demiology determine an individual’s disease predisposition and 
progression and detect individual susceptibility to diseases dur-
ing all periods from preclinical steps to death. 
The first molecular epidemiological study from our group was 
published in 2000 and deletion polymorphisms in the GSTM1 
and GSTT1 genes were identified as breast cancer risk factors 
[21]. Inherited differences in activation or deactivation of envi-
ronmental carcinogens, such as by glutathione-S-transferases 
coded by GSTM1 and GSTT1 modify individual susceptibility 
to breast cancer development. Moreover, individuals with the 
Val allele of GSTP1 Ile105Val have a 0.3-fold reduced risk for 
breast cancer [22]. Both the GSTM1 and GSTT1 genetic poly-
morphisms have gene-gene interaction effects with NAT1 or 
two polymorphisms to modify breast cancer risk, although NAT 
1 and 2 have no significant independent effect on breast cancer 
risk [23]. The Gln containing homogenotype of the XRCC1 
codon 399 polymorphism is associated with a 3.8-fold higher 
risk for premenopausal breast cancer [24].
Not only xenobiotic metabolic polymorphisms of xenobiotic 
metabolism but those of estrogen metabolism are involved in 
breast cancer risk. Breast cancer risk decreases 0.4-fold in wom-
en with the XbaI X allele containing genotypes [25]. The cate-
chol O-methyl transferase (COMT) Val158Met gene, which 
codes key enzymes involved in converting catechol-estrogens 
to methoxy-estrogens, reveals a 1.7-fold increased risk for breast 
cancer [26]. The glutathione S-transferase (GST) polymorphisms 
for xenobiotic metabolism and the COMT polymorphism for 
estrogen metabolism have a combined effect, which increases 
breast cancer risk [27]. The cytochrome P450 1A1 (CYP1A1) 
genes, which codes a key enzyme involved in converting es-
trone/E2 to catechol-estrogens such as 2-hydroxyestradiol shows 
a 0.3-fold decreased risk for breast cancer compared to CA/CA 
diplotypes of CYP1A1 MspI (rs4646903) and Ile462Val poly-
morphisms (rs1048943) [28]. The CYP17 gene, which codes a 
key enzymes involved in the conversion of 17-hydroxypreg-
nenolone to 17-hydroxyprogesterone or dehyroepiandrosterone 
to androstenedione during estrogen synthesis, has no indepen-
dent role in breast cancer development [29]. The SULT1A1 and 
E1 genes coding human sulfotransferases are involved in con-
verting estrogen to E2. The CTA-CCA haplotype of SULT1E1 
(c.779G>A, *14A>G, and *85C>T) shows a 0.5-fold reduced 
risk of breast cancer, whereas no significant association with 
the SULT1A1 genes was found in our study [30]. A number 
of DNA repair, genes associated with cytokines, and cell cycle 
control are related to breast cancer risk. Women with a decrease 
in the ATM ATTGT haplotype, composed of 5144A>T, IVS21 
+1049T>C, IVS33-55T>C, IVS34+60G>A, and 3393T>G 
have an, increased breast cancer risk [31]. The T allele contain-
ing the RAD52 2259, -93 GG genotype of hMLH1 and the T 
allele containing the ERCC1 8092 genotype are associated with 
a 1.3-1.7-fold increased breast cancer and these of RAD 52 and 
ERCC1 354 genotypes are more evident in ER/PR negative cas-
es by up to 2.0 fold [32]. X-ray cross-complementing group 3 
(XRCC3) is protein components involved in the homologous 
recombination repair pathway that repairs radiation-induced 
DNA damage. Our study showed no association with breast 
cancer risk; however, a meta-analysis including our results sug-
gested that the Met allele containing the XRCC3 Thr241Met 
genotypes weakly increases breast cancer risk compared to the 
Thr/Thr genotype [33]. Other genes involved in the DNA re-
pair system, such as hOGG1 Ser326Cys, XRCC4 c. 921G>T, 
RAD51 nt 135G>C and nt 172G>T, LIG1exon 6 nt 551A>C, 
ERCC1 3VUTRc. 8092C>A, and hMLH1 5Vexon8 Ile219Val 
(A>G), are unlikely to play a modifying role in individual sus-
ceptibility to breast cancer among Korean women [34]. Cyclin 
D1 (CCND1) and CDK-activating kinase 7 (CDK7) genes code 
key regulators of cell cycle progression and cell development. 
Women carrying the CDK7 TT genotype have a weakly in-
creased risk of breast cancer (1.4 fold), whereas no significant 
association with the CCND1 genetic polymorphism was found 
[36]. CDK7 has a weak gene-gene interaction with ESR1 P325P; 
the combination those with the CDK7 TT and ESR1 P325P 
combination CC had a 1.7-fold increased risk for breast can-
cer [35].
Innate immune and inflammatory responses may be related 
to breast cancer development. Endogenous cytokine families 
involved in inflammatory and immunological responses in-
clude interleukin (IL)-1, IL-1α, IL-1β and an IL-1 receptor an-
tagonist encoded by IL-1RN. The two-alleles of IL-1RN 86-bp 
VNTR are associated with a decreased breast cancer risk with 
marginal significance, whereas the C containing genotypes of 
the IL-1βB -31C/T polymorphism have no independent role in 
a decreased risk for breast cancer. However the combination 
of both the IL-1β C-allele and IL-1RN two-allele containing 
genotypes have a gene-gene interaction that significantly de-
creases the risk of breast cancer by 0.6-fold [36]. Tumor necro-82  SueK.Park,etal.
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sis factor beta (TNF-β) is a pro-inflammatory cytokine secret-
ed by lymphocytes and has both anti-tumor and pro-cancer 
activity and Transforming growth factor beta (TGF-β) acts as 
a potent inhibitor of proliferation of epithelial, endothelial and 
hematopoietic cells. Individuals, particularly postmenopausal 
women, with C and G containing genotypes of TGF-β1 T29C 
and TNF-β A252G are at a 1.3- and 1.7-fold increased risk for 
breast cancer, respectively [37].
Apoptosis is important in cancer development and hypoxia 
inducible factor 1 (HIF-1) and caspase-8 (CASP8) mediate a 
broad cellular response, which leads to tumorigenesis and tu-
mor aggressiveness. The Ser allele contained in the HIF-1A 
P582S genotypes and the T allele contained in the CASP8 gen-
otypes are weakly involved in breast cancer susceptibility (1.1 
fold). These associations are particularly prominent in aggres-
sive tumors such as larger tumor 2 cm (10 fold) with HIF-1A 
genes and in ER or PR negative cases (1.3 fold) with the CASP8 
gene, respectively [38,39].
We screened candidate genetic variants in an affordable, 
high-throughput manner using two kinds of Illumina Gold-
enGate. These genes are involved in the pathways controlling 
the innate immune and inflammatory responses, cytokines, 
apoptosis/anti-apoptosis, and DNA repair. Seventeen genes 
related to innate immunity on the first 1,536 single-nucleotide 
polymorphism (SNP) panel such as OR10J3, FCER1A,NCF4, 
CNTNAP1, CTNNB1, KLKB1, ITGB2, ALOX12B, KLK2, 
IRAK3, KLK4, STAT6, NCF2, CCL1, C1QR1, MBP, and NOS1, 
were associated with breast cancer risk in single SNP analyses. 
Of them, OR10J3 (rs2494251) and FCER1A (rs7548864) were 
selected as significant candidate genes related to breast cancer 
risk in Korean women (p=1.2×10
-4 and 7.7×10
-4, respective-
ly) [40]. Five genes on the second 1,536 SNP panel such as IL1A, 
TNFRSF10B, TNFRSF1B, ICAM, and TNFSF9 were primari-
ly screened. Of them, a common genetic variant in IL1A was 
strongly associated with breast cancer risk (p=6×10
-7). We 
have performed a large-scale genome-wide association studies 
for breast cancer risk to find susceptible genetic factors among 
Korean women and those findings will be published shortly.
Gene-environment interaction
GST genetic variations are related to alcohol consumption, 
and modify breast cancer risk up to 7-fold [21]. A significant 
interaction was observed between the GSTP1 genotype and 
alcohol consumption (p for interaction=0.01), compared with 
never-drinking women with the Ile/Ile genotype. Ever-drink-
ing women with the GSTP1 Val allele had almost a 3-fold in-
creased risk of for breast cancer, whereas never-drinking wom-
en with the Val allele had a 0.5-fold reduced risk. A similar in-
teraction with alcohol consumption was reported in cysteine-
containing allele positive genotypes of CYP2E1 in the 5´ flank-
ing region (RsaI) and the interaction increased breast cancer 
risk up to 3-fold. In contrast, no significant interaction was ob-
served between the ALDH2 Glu487Lys polymorphism and 
alcohol consumption in Korean women [41].
GSTs gene variations interacted with reproductive factors 
such as a high risk group for parity (age at first full-term preg-
nancy ≥30 years and nulliparous women) to increase the breast 
cancer risk up to 88-fold [42]. A combined effect on breast can-
cer risk was also observed between body mass index (BMI); 
women with a higher BMI and the IL-1RN non-2 allele had a 
1.7-fold higher risk than women with a lower BMI and the IL-
1RN*2 genotypes [36]. CYP17 and TGF-β1 genes also show a 
gene-environment interaction with BMI. Heavier women (BMI 
>22 kg/m
2 or median level BMI >22.8 kg/m
2) with the CYP17 
A1 and TGF-b1 c allele containing genotypes have a 2-fold in-
creased risk for breast cancer [29,37]. The interaction effect 
between the CA/CA diplotypes in CYP1A1 MspI, Ile462Val 
polymorphisms, and BMI also had a more pronounced effect 
than the CYP1A1 gene effect. Women with a lower BMI have 
a 0.2-fold decreased risk for breast cancer. The CYP1A1 diplo-
types had another gene-environment interaction with lifetime 
estrogen exposure. Women with a shorter lifetime estrogen 
exposure have a 0.2-fold significantly reduced risk for breast 
cancer [28].
Breast cancer survivals
Estrogen is conjugated by sulfotransferases, and SULT1E1 has 
the highest affinity for estrogens. A SULT1E1 polymorphism 
related to better breast cancer survival, particularly among wom-
en with ER negative breast cancer [30].
A summary of our international collaboration on a case-con-
trol study for genetic polymorphism of breast cancer shows rel-
atively weak power in terms of sample size of a Korean study 
showed very good results on breast cancer [43].
Although data on the influence of inherited factors to breast 
cancer is limited, differences in genetic constitution by different 
ethnic groups may be a clue to explain racial differences. The 
KOJACH study is an example of an international collaborative 
study on colorectal and breast cancer that included three geo-
graphically and historically close countries, Japan, Korea, and 
China, but they have preserved their own cultures for a long 
time. This study will provide additional supportive results of 
protective and risk factors with increased power due to data 
pooling.
Future trends in breast cancer in Korea
According to statistical projections, the Korean population 
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countries in Asia including Korea are now experiencing low 
fertility and an aged society, so we expect that more cancer cases 
will occur in Korea in the near future.
Korea has been experiencing a considerable change in life-
style pattern including changes in eating habits. For example, 
grain intake has been declining continuously, whereas meat 
consumption has risen steadily over the last four decades. Ad-
ditionally, dramatic changes in reproductive behaviors, includ-
ing age at first marriage, fertility, and age at menarche may have 
the greatest contribution [44]. If the current trend continues, 
we can expect breast cancer incidence to rise gradually in the 
future. Currently, more and more mothers are resorting to for-
mula feeding in Korea. This phenomenon is probably due to 
the increasing role of working women in a changing social en-
vironment such as difficulty feeding their babies during work-
ing hours. However, special attention should be given to pro-
mote breast feeding by organizing public campaigns.
Age-adjusted breast cancer incidence rates among Asian mi-
grants living in Los Angeles suggest lifestyle factors including 
diet may play a role in breast cancer etiology. Korean migrants 
showed the lowest rate of breast cancer compared to Japanese, 
Chinese, and even Filipinos, probably due to the relatively short 
history of immigration to the U.S. [45]. However, when com-
pared to the incidence among Koreans living in Korea, Kore-
an migrants have substantially higher incidence levels of breast 
cancer than women in their mother country, which suggests 
that breast cancer might further be increased based on chang-
es in environmental habits including diet. Numerous epide-
miological studies have been conducted on the possibility of a 
further increase in breast cancer in Korea. Based on mortality 
trends over the last two decades, breast cancer mortality in 
Korea is estimated to increase almost four times by 2020 com-
pared to 1983 [20]. 
CONTROL STRATEGY OF BREAST CANCER
Control strategy against the breast cancer burden in Korea
Disease burden is composed of the burden due to premature 
death and disability, and cancer imposes a considerable burden 
on the nation’s economy. The estimated total cost caused by 
cancer in 2005 is an estimated 14 billion USD, which is 1.7% 
of the national GDP, and 0.7 billion USD is the estimated cost 
for breast cancer alone (0.1% of GDP). Thus, reducing cancer 
burden by promoting national cancer control activities becomes 
one of the most urgent health issues in Korea [3-5].
World Health Organization (WHO) declared in 2002 that 
one third of all human cancers can be prevented by stopping-
smoking, receiving vaccinations, and diet control. Another one 
third can be cured through early detection such as screening, 
and the remaining one third will require palliative medicine to 
ensure quality of life. At the General Assembly in May 2005, 
192 WHO member states accepted a resolution for “Cancer 
Prevention and Control,” which prioritized cancer control for 
the first time.
The Korean government began implementing the National 
Cancer Screening Program (NCSP) in 1999 and has expanded 
its target population and target cancers since then. Currently, 
the NCSP provides free screening for (stomach, breast, cervi-
cal, liver, and colorectal cancers) to Medical Aid and National 
Health Insurance Corporation (NHIC) beneficiaries within the 
lower 50% contribution which covers about 56% of the entire 
population. By initiating the NCSP in 1999, the Korean govern-
ment has expanded its target population and target cancers. 
Currently, the NCSP provides both Medical Aids beneficiaries 
and low-income NHIC beneficiaries with free-of-charge screen-
ing services for stomach, breast, cervical, liver, and colorectal 
cancers [46].
Korea has a system of universal coverage of medical health 
care through National Health Insurance [47]. The eligible pop-
ulation that requires screening includes women ≥30 years old 
and men over ≥40 years old, and the target population was 
about 13 million in 2009 [48]. Most of these patients are NHIC 
beneficiaries, and about 4% are Medical Aid recipients. The ac-
tual number of patients covered by the NSCP was 7.3 million 
(coverage rate, 56.2%) in 2009 [48,49]. These patients receive 
free screening services for five major types of cancer by the 
guidelines. The Ministry of Health and Welfare, in collabora-
tion with related academic societies, has developed national 
protocol guidelines for organized cancer screening in Korea. 
Breast cancer screening was introduced at the start of the NCSP, 
and women aged 40 or older are recommended to undergo a 
mammogram every 2 years.
Screening rates based on the NCSP information system 
were 12.7% in 2002, and improved gradually to 32.7% in 2009. 
The nationwide survey for health screening performance rate 
showed that the screening rates for stomach, colorectal, liver, 
breast, and cervical cancers were 38.8% in 2004 and 56.6% in 
2010 when the NCSP and the screening program were sup-
ported by National Health Insurance in Korea. Among people 
who had screening performed for five cancer types, 67.8% used 
the organized cancer screening program in 2010. The nation-
wide survey also revealed that the life-time screening rates for 
individuals, who had taken at least one cancer screening in the 
given year under the screening guidelines recommended by 
the National Cancer Center and the Ministry of Health and 
Welfare was 72.1% in 2009 [49].
Survival rate is a key barometer indicating the effectiveness 
of the NCSP. Although overall cancer mortality has not been 84  SueK.Park,etal.
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reduced significantly, the 5-year survival rate is beginning to 
improve. As announced by the Korea Central Cancer Regis-
try, we have a very high 5-year survival rate for cancers of the 
thyroid, breast, and cervix of more than 80%. Five-year surviv-
al rates for female breast cancer have improved during the last 
15 years from 78.0% in 1993-1995 to 90.0% in 2004-2008 [2]. 
These data indicate that the improvement in survival rate may 
be partly due to early diagnosis at an earlier breast cancer stage.
The most noteworthy figure is the higher survival rate of 
stomach and liver cancer in Korea and Japan than that in the 
U.S.. The survival rates for colorectal and breast cancer are very 
similar among Korea, Japan, and the U.S. private clinics par-
ticipate in breast cancer screening including privately-insured 
patients. The participation rate in breast cancer screening is 
contributed both by the national screening program and pri-
vate screening. The average rate of participation in public and 
private cancer screening programs including the NCSP 61.1% 
for breast cancer and 62.9% for cervical cancer in 2010 [49]. 
The participation rate in NCSP breast screening has also in-
creased from 18.2% in 2004 to 35.0% in 2008 [50]. Although 
the participation rate for NCSP breast cancer screening is in-
creasing for all target populations that of the Medical Aids re-
cipients is in a steady state compared to that in NHIC benefi-
ciaries [51]. Compared to the cancer screening participation 
rate in the U.S., which is 66.9% for breast and 77.9% for cervi-
cal cancer screening, Korea’s rate still remains relatively low. 
This is partly influenced by advertisements about the signifi-
cance of early cancer detection and the organized cancer screen-
ing program.
To address cancer at the national level, the Korean govern-
ment developed a 10-year plan for cancer control in 1996. As 
part of the plan, the NCSP was introduced in 1999, and in 2001, 
the National Cancer Center headquarters became involved in 
the fight against cancer.
The legal framework for controlling cancer was later estab-
lished in 2003 when the National Cancer Control Law was leg-
islated. Nine regional cancer centers were designated in 2004, 
and in 2006, the second term 10-year plan for cancer control 
was initiated [52].
National action for primary prevention
The second-term plan aims to reduce the cancer burden sig-
nificantly through primary, secondary, and tertiary preventive 
efforts. The primary prevention programs currently underway 
are for strengthening national prevention campaigns such as 
smoking cessation and dissemination of cancer prevention 
guidelines. Providing the target population with mass-screen-
ing service, strengthening financial support and improving 
quality of life through quality care for cancer patients are some 
of the government’s secondary and tertiary programs. The gov-
ernment is also strengthening its capacity for cancer control 
through a sophisticated nationwide cancer registry program, 
investing more in research and development activities, enhanc-
ing public awareness about all aspects of cancer, and nurturing 
next-generation cancer specialists.
In 2007, the government developed ten codes of conduct for 
cancer prevention to help the general public lead a cancer-free 
life by following prevention guidelines. The codes of conducts 
include quitting smoking, eating sufficient fruits and vegeta-
bles, reducing salt intake, not drinking alcohol excessively, ex-
ercising regularly, maintaining a healthy body weight, receiv-
ing a hepatitis B vaccine, maintaining safe sexual behavior, and 
avoiding occupational cancer risks. Various leaflets and post-
ers encourage public awareness for cancer prevention.
The National Cancer Information Center was opened in 
2005. The web portal services includes information on the var-
ious characteristics of all types of cancers, FAQs, national can-
cer statistics, a large selection of educational materials, and a 
medical vocabulary services. The center also provides the pub-
lic with counseling at a toll-free phone number. To increase 
public awareness about the importance of cancer prevention 
activities, the National Cancer Control Act designated March 
21 as cancer prevention day. The first anniversary was cele-
brated and included many events to increase knowledge about 
cancer prevention activities.
The Center for Cancer Prevention and Early Detection was 
opened at the National Cancer Center, Korea in June 2007 to 
provide and develop effective early screening tests in Korea. A 
customized cancer prevention service is provided at this facil-
ity. Many invited guests from the government, national assem-
bly, businessmen, foreign ambassadors, professors, scientists, 
and outstanding international figures from the Nation Cancer 
Center, Japan, International Agency for Research on Cancer, 
and the National Cancer Institute, U.S. came to celebrate this 
facility on June 18 and 19, 2007. The President of the Republic 
of Korea delivered a special message on “Cancer is preventable, 
and further strengthening of early detection is needed to con-
quer the cancer. We call that day the beginning of the era of 
cancer prevention.”
Voluntary movement by non-governmental organizations
To increase public awareness about the importance of cancer 
prevention, various types of exhibitions and campaigns have 
been designed and conducted by non-governmental organiza-
tions, including the Korean Breast Cancer Society and Korean 
Breast Foundation. Founded in 2000 as a non-profit organiza-
tion, the Korean Breast Foundation aims to improve the qual-
ity of life for women through public awareness, various cam-BreastCancerinKorea 85
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paigns, medical aids for patients with poor economic status, 
and web-based medical consultations. During the Pink Ribbon 
campaign in several major cities each year, free mammogra-
phy examinations were provided irregularly but continuously. 
The Pink Illumination Exhibition, organized by Seoul City and 
the Pink Ribbon Love Marathon was performed to provide do-
nations for support of patients with cancer.
The Korea Breast Cancer Society is an academic society com-
posed of scientists who conduct research on the etiology, epi-
demiology, diagnosis, and treatment of the disease. The society 
has always been the most active in leading cancer prevention 
campaigns compared to any other group in Korea. The Global 
Breast Cancer Conference organized by the Korean Breast Can-
cer Society (KBCS) has been held in conjunction with the 7th 
Biennial Meeting of the Asian Breast Cancer Society in Seoul, 
Korea. Not only academic activities but also social support by 
the KBCS members was encouraged. 
A self-supported nation-wide group of breast cancer survi-
vors is being developed in Korea. Korea Venus is a name of 
breast cancer survivors at Seoul National University Hospital 
and about 500 survivors have various activities. Similar self-
supported groups are present in each hospital in Korea. 
CONCLUSION
The war against cancer was declared in the U.S. by Nixon in 
1971, and cancer mortality started to decline in 1991. The Jap-
anese government initiated their National Cancer Control Plan 
in 1965, and National Cancer Screening Program for breast 
cancer was initiated in 1987. In Korea, major epidemiological 
studies to identify breast cancer risk factors were initiated about 
20 years ago in the late the 1980s, and the fight against cancer 
was first declared by the Korean government in 1996. A nation-
al screening program against breast cancer was launched in 
1999. The 5-year survival rate has increased in Korea during 
the last 15 years due to improvements in medical facilities, di-
agnosis and treatment, and the creation of the health insurance 
system. Thus, overall cancer mortality has started to decrease; 
however, the breast cancer death rate and incidence rates con-
tinue to increase today.
We have a final goal of fundamentally reducing the cancer 
mortality rate from the current 116.7 persons/100,000 in 2005 
to 94.1 in 2015 (19.4%). We also strive to improve the 5-year 
survival rate in Korea from 45.9% in 2005 to 54% in 2015 dur-
ing the second term of the National Cancer Control Plan. Since 
embarking on an economic development project in the early 
1960s, Korea has achieved an incredible success that has dra-
matically transformed the Korean economy from an agricul-
tural country into a highly advanced industrial nation during 
a relatively short period of time. Korea is now experiencing a 
rapidly ageing population, mainly due to increased life expec-
tancy. Life expectancy for males is 75 years and that for females 
is 82 years. The system of universal healthcare coverage based 
on the national health insurance program was introduced in 
1988 when the Seoul Olympic Games were held. An export-
driven economic development strategy resulted in per capita 
gross national income from 87 USD in 1962 to 18,000 USD in 
2006. Many aspects of women’s health have also changed, but 
the statement that “a breast that has never lactated is more lia-
ble to become cancerous,” as described by British doctor JE 
Lane-Claypon in 1926 is still true.
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